Icon Plc: The Sale Was Well-Timed
We purchased shares of Icon in March 2024 for ~$323.00 per share. Why did we sell our ICLR position and move on? Click here ...
Allakos Inc. Enters into Agreement to Be Acquired by Concentra Biosciences, LLC for $0.33 in Cash per Share
Allakos’ Board of Directors has unanimously determined that the acquisition by Concentra is in the best interests of all Allakos shareholders and, following the unanimous recommendation of Allakos’ ...
Organovo Provides Update on Cash and Nasdaq Continued Listing Requirements
The Company’s preliminary cash and cash equivalents balance was approximately $11.3 million as of the end of the fiscal year on March 31, 2025. Organovo’s preliminary net cash utilization during the ...